Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: Enbrel (Etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: Blood and marrow transplant clinical trials network protocol

Gregory A. Yanik, Mary M. Horowitz, Daniel J. Weisdorf, Brent R. Logan, Vincent T. Ho, Robert J. Soiffer, Shelly L. Carter, Juan Wu, John R. Wingard, Nancy L. Difronzo, James L. Ferrara, Sergio Giralt, David K. Madtes, Rebecca Drexler, Eric S. White, Kenneth R. Cooke

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: Enbrel (Etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: Blood and marrow transplant clinical trials network protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences